CHRISTOPHER DAO: Open Payments
NPI 1366103764 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 122 payments from 30 companies in 2025. Trend: 2023 $1,601 · 2024 $2,497 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $341 |
| Novo Nordisk Inc | 20 | $336 |
| AstraZeneca Pharmaceuticals LP | 8 | $250 |
| Lilly USA, LLC | 9 | $154 |
| PFIZER INC. | 11 | $144 |
| Teva Pharmaceuticals USA, Inc. | 7 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $114 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Ardelyx, Inc. | 4 | $59 |
Products named: Ozempic, AIRSUPRA, ALLODERM, MOUNJARO, AJOVY, XIFAXAN, JARDIANCE, PREVNAR 20.
Industry payments across VA — which companies pay providers there.
